L

Liver Associates of Texas, P.A. | Fannin Office

Research site

(Unclaimed)

Location

University of Texas Professional Building, 6410 Fannin Street, Suite 225, Houston, Texas, United States of America

Site insights

Top conditions

Top treatments

Obeticholic Acid

Elafibranor

Ursodeoxycholic Acid

Emricasan

OCA

Selonsertib

Cilofexor

UDCA

Firsocostat

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 14 total trials

A Study of Elafibranor in Adults With Primary Biliary Cholangitis and Inadequate Response or Intolerance to Ursodeoxycholic Acid. (ELSPIRE)

The participants in this study will have confirmed PBC with inadequate response or intolerance to Ursodeoxycholic acid (UDCA), which is a medication...

Enrolling

Primary Biliary Cholangitis

Other: Placebo

Drug: Elafibranor

IDEAL: Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC) and an Incomplete Response or Intolerance to Ursodeoxycholic Acid (UDCA)

To Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects with Primary Biliary Cholangitis (PBC) and an Inco...

Enrolling

Primary Biliary Cholangitis

Drug: Placebo

Drug: Seladelpar 10 mg

Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) (ELATIVE)

The participants of this study will have confirmed Primary Biliary Cholangitis (PBC) with inadequate response or intolerance to ursodeoxycholic acid...

Active, not recruiting

Primary Biliary Cirrhosis

Drug: Placebo

Drug: Elafibranor 80mg